Inspire Medical Systems Gross Margin 2017-2025 | INSP
Current and historical gross margin for Inspire Medical Systems (INSP) over the last 10 years. The current gross profit margin for Inspire Medical Systems as of March 31, 2025 is %.
| Inspire Medical Systems Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-03-31 | $0.84B | $0.71B | 84.76% |
| 2024-12-31 | $0.80B | $0.68B | 84.68% |
| 2024-09-30 | $0.76B | $0.64B | 84.66% |
| 2024-06-30 | $0.71B | $0.60B | 84.70% |
| 2024-03-31 | $0.66B | $0.56B | 84.57% |
| 2023-12-31 | $0.63B | $0.53B | 84.48% |
| 2023-09-30 | $0.57B | $0.48B | 84.21% |
| 2023-06-30 | $0.53B | $0.44B | 83.65% |
| 2023-03-31 | $0.47B | $0.39B | 83.69% |
| 2022-12-31 | $0.41B | $0.34B | 83.78% |
| 2022-09-30 | $0.35B | $0.29B | 84.15% |
| 2022-06-30 | $0.30B | $0.26B | 85.33% |
| 2022-03-31 | $0.26B | $0.22B | 85.50% |
| 2021-12-31 | $0.23B | $0.20B | 85.41% |
| 2021-09-30 | $0.20B | $0.17B | 85.07% |
| 2021-06-30 | $0.18B | $0.15B | 85.14% |
| 2021-03-31 | $0.13B | $0.11B | 85.07% |
| 2020-12-31 | $0.12B | $0.10B | 85.22% |
| 2020-09-30 | $0.10B | $0.08B | 85.42% |
| 2020-06-30 | $0.08B | $0.07B | 83.95% |
| 2020-03-31 | $0.09B | $0.07B | 83.91% |
| 2019-12-31 | $0.08B | $0.07B | 82.93% |
| 2019-09-30 | $0.07B | $0.06B | 80.56% |
| 2019-06-30 | $0.06B | $0.05B | 81.25% |
| 2019-03-31 | $0.06B | $0.05B | 80.70% |
| 2018-12-31 | $0.05B | $0.04B | 80.39% |
| 2018-09-30 | $0.04B | $0.04B | 81.82% |
| 2018-06-30 | $0.04B | $0.03B | 81.58% |
| 2018-03-31 | $0.03B | $0.03B | 81.82% |
| 2017-12-31 | $0.03B | $0.02B | 82.14% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.801B | $0.803B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.457B | 60.38 |
| Hims & Hers Health (HIMS) | United States | $12.904B | 134.07 |
| Doximity (DOCS) | United States | $11.414B | 52.84 |
| Tempus AI (TEM) | United States | $11.164B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.284B | 0.00 |
| Hinge Health (HNGE) | United States | $3.571B | 0.00 |
| Privia Health (PRVA) | United States | $2.402B | 164.21 |
| 10x Genomics (TXG) | United States | $1.737B | 0.00 |
| Schrodinger (SDGR) | United States | $1.631B | 0.00 |
| Phreesia (PHR) | United States | $1.585B | 0.00 |
| Azenta (AZTA) | United States | $1.576B | 73.25 |
| Enovis (ENOV) | United States | $1.573B | 8.77 |
| Clover Health Investments (CLOV) | United States | $1.545B | 0.00 |
| Omnicell (OMCL) | United States | $1.324B | 23.36 |
| Evolent Health (EVH) | United States | $1.166B | 99.30 |
| Claritev (CTEV) | United States | $0.652B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.559B | 0.00 |
| Standard BioTools (LAB) | United States | $0.532B | 0.00 |
| Veradigm (MDRX) | United States | $0.503B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.487B | 0.00 |
| Talkspace (TALK) | United States | $0.421B | 125.75 |
| TruBridge (TBRG) | United States | $0.353B | 783.33 |
| Outset Medical (OM) | United States | $0.328B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.258B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.240B | 0.00 |
| CapsoVision (CV) | United States | $0.185B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.161B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.160B | 0.00 |
| American Well (AMWL) | United States | $0.140B | 0.00 |
| Pulmonx (LUNG) | United States | $0.134B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.118B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.118B | 0.00 |
| CareCloud (CCLD) | United States | $0.104B | 3.95 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.099B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.083B | 0.00 |
| 111 (YI) | China | $0.063B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |